Investment
Features
FeesSafety
Academy
More
Pluang+

Invesco Dividend Achievers ETF expected to underperform broad market through 2027, Hold rating maintained.

Analyst Insights
24 Sep 2026
Seeking Alpha
View Source
Neutral
Invesco Dividend Achievers ETF expected to underperform broad market through 2027, Hold rating maintained.

The Invesco Dividend Achievers ETF (PFM) is expected to underperform the broad market ETF IVV through 2027 due to its value tilt and weaker quality and growth-at-a-reasonable-price (GARP) characteristics. Despite no critical flaws in its portfolio, PFM's historical performance since 2005 has been consistently disappointing, leading to a cautious Hold rating. The analyst remains cautiously optimistic about the macroeconomic outlook but does not see a reason to be bearish on PFM at this time.

PFM ETF market context shows mixed activity among US stocks on Pluang. For readers following PFM, here is Pluang's market snapshot as of Sep 25, 2026 03:11 WIB: Of 150 US stocks priced, 61 rose and 87 fell. Notable movers include FCEL at USD 16.40 with a -4.54% change and 100% buy orders, FUBO at USD 9.69 down 4.34% with 58% sell orders, and META at USD 776.36 up 4.34% with 60% sell orders. Typical hold times range from 34 to 126 days.

More News

Costco beats Q4 EPS estimates with $6.75 despite slight revenue miss, driven by strong sales growth and tariff refunds.

Costco beats Q4 EPS estimates with $6.75 despite slight revenue miss, driven by strong sales growth and tariff refunds.

Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...

Company Fundamentals
Bullish
2 hours ago
Vistry Group cuts profit forecast after £661m H1 loss and plans strategic downsizing.

Vistry Group cuts profit forecast after £661m H1 loss and plans strategic downsizing.

Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...

Company Fundamentals
Bearish
3 hours ago
Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...

Company Fundamentals
Bearish
3 hours ago
Gene therapy sura-vec shows lasting improvement in diabetic retinopathy after one treatment, no serious side effects.

Gene therapy sura-vec shows lasting improvement in diabetic retinopathy after one treatment, no serious side effects.

REGENXBIO announced positive 3-year results from its Phase II ALTITUDE trial of surabgene lomparvovec (sura-vec) for non-proliferative diabetic retinopathy (NPDR). A single in-office gene therapy dose led to over 60% of participants achieving more th...

Company Fundamentals
Bullish
4 hours ago
Ethereum breaks year-long pattern with higher high, eyes $3,400 but daily momentum warns of pullback.

Ethereum breaks year-long pattern with higher high, eyes $3,400 but daily momentum warns of pullback.

Ethereum (ETH) has printed its first higher high since its August 2025 peak, breaking a year-long pattern of lower highs. It surpassed the $2,438 resistance level, which has now turned into support, signaling a more bullish weekly structure. However,...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App